EcoDrugPlus

Protein Kinase C Beta

Ensembl ID : ENSOCUG00000013916
Gene Symbol: PRKCB
2 Cross references
284 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSOCUG00000010843
Gene Symbol: PRKCD
3 Cross references
280 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSOCUG00000013785
Gene Symbol: PRKCE
2 Cross references
315 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSOCUG00000015859
Gene Symbol: PRKCH
3 Cross references
237 Possible Orthologues:

Protein Kinase C Gamma

Ensembl ID : ENSOCUG00000007624
Gene Symbol: PRKCG
2 Cross references
199 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSOCUG00000014563
Gene Symbol: PRKCI
3 Cross references
193 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSOCUG00000009863
Gene Symbol: PRKCQ
2 Cross references
203 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSOCUG00000022585
Gene Symbol: PRKD1
2 Cross references
204 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSOCUG00000007411
Gene Symbol: PRKD3
3 Cross references
270 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Beta

Ensembl ID : ENSOCUG00000012937
Gene Symbol: PRKACB
2 Cross references
297 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSOCUG00000011398
Gene Symbol: PPP3CA
4 Cross references
230 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSOCUG00000003282
Gene Symbol: PTK2
2 Cross references
325 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).